These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18654647)

  • 1. Addressing hemolysis in an infant due to mother-infant ABO blood incompatibility.
    Martin S; Jerome RN; Epelbaum MI; Williams AM; Walsh W
    J Med Libr Assoc; 2008 Jul; 96(3):183-8. PubMed ID: 18654647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.
    Kaplan M; Vreman HJ; Hammerman C; Leiter C; Rudensky B; MacDonald MG; Stevenson DK
    Acta Paediatr; 1998 Apr; 87(4):455-7. PubMed ID: 9628306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and etiology of neonatal hyperbilirubinemia.
    Sarici SU
    J Trop Pediatr; 2010 Apr; 56(2):128-9. PubMed ID: 19502601
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO incompatibility: which one matters?
    Sarıcı SU
    Turk J Pediatr; 2014; 56(2):216. PubMed ID: 24911864
    [No Abstract]   [Full Text] [Related]  

  • 8. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia.
    Khurana R; Batra P; Faridi M; Khan N
    Trop Doct; 2019 Jul; 49(3):201-204. PubMed ID: 30943888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
    Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
    Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.
    Metcalf RA; Khan J; Andrews J; Mayock D; Billimoria Z; Pagano MB
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):632-634. PubMed ID: 30044350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility.
    Huizing K; Røislien J; Hansen T
    Acta Paediatr; 2008 Oct; 97(10):1362-5. PubMed ID: 18616629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply: To PMID 24382531.
    Akgül S; Korkmaz A
    Turk J Pediatr; 2014; 56(2):217. PubMed ID: 24911865
    [No Abstract]   [Full Text] [Related]  

  • 14. [PROGNOSIS IN NEONATAL HEMOLYSIS CAUSED BY ABO INCOMPATIBILITY NOT TREATED WITH EXCHANGE TRANSFUSION. (PRELIMINARY REPORT)].
    FOHL E; LOMBOS O
    Orv Hetil; 1964 Nov; 105():2073-5. PubMed ID: 14228946
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolysis in ABO-incompatible liver transplantation.
    Angstadt J; Jarrell B; Maddrey W; Munoz S; Yang SL; Moritz M; Carabasi A
    Transplant Proc; 1987 Dec; 19(6):4595-7. PubMed ID: 3321627
    [No Abstract]   [Full Text] [Related]  

  • 17. ABO hemolytic disease of newborn : Does newborn's blood group a risk factor?
    Bel Hadj I; Boukhris R; Khalsi F; Namouchi M; Bougmiza I; Tinsa F; Hamouda S; Boussetta K
    Tunis Med; 2019 Mar; 97(3):455-460. PubMed ID: 31729720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolysis during immunoglobulin therapy].
    Muñoz J; García A; Jordán C; Rubió A; Ferrán C; Martínez Matos JA
    Sangre (Barc); 1996 Feb; 41(1):72-3. PubMed ID: 8779043
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
    Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
    J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
    Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.